Time to Add aHSCT to Standard Care in RRMS? : vimarsana.com

73% of patients with relapsing remitting multiple sclerosis were disease free 5 years after aHSCT treatment, and more than half reported improved disability.

Related Keywords

Sweden , Stockholm , Uppsala , Uppsala Lan , Dalarna , Kopparberg , Swedish , Joachim Burman , Clinical Research Dalarna , Swedish Research Council , Marcus Wallenberg Foundation , Regional Research Council , Department Of Medical Sciences , Swedish Society Of Medicine , Swedish Society For Medical Research , Uppsala University , Kurtzke Expanded Disability Status Scale , Medical Sciences , Region Stockholm , Swedish Society , Medical Research , Neurology Neurosurgery , Multiple Sclerosis Ms , S Multiple Sclerosis , Transplantation Of Stem Cells , Ransplantation Of Hematopoietic Stem Cells , Hematopoietic Stem Cell Transplant , Stem Cell Transplantation , Stem Cell Therapy , Tem Cell Haematopoietic Stem Transplant , Sct Hematopoietic Stem Cell Transplantation Hsct Haematopoietic ,